This article is more than 5 years old. Information may no longer be current.

AcrySof foldable lens safe, effective for secondary pediatric IOL implantation

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WAIKOLOA, Hawaii – Alcon’s AcrySof foldable lens was found to be safe and effective in treating aphakic pediatric patients who underwent secondary IOL implantation, according to a study presented here.

“This is really the first study of its kind,” Tracy C. Crnic-Rein, MD, told attendees of the annual meeting of the American Association for Pediatric Ophthalmology and Strabismus. Dr. Crnic-Rein said previous studies on secondary pediatric IOL implantation reported good results with rigid IOLs. However, Dr. Crnic-Rein said no study has accessed the safety and efficacy of soft, foldable and injectable IOLs for the procedure.

This study reviewed the records of 55 eyes of 36 patients with a minimum of 6 months follow-up. “All children had congenital or developmental cataract, and many had no contact lens compliance,” Dr. Crnic-Rein said. Records were analyzed for the age of the child at surgery, preoperative and postoperative refraction and visual acuity, anisometropia and complications.

“Since most children had poor vision prior to the procedure, we looked to see if there was a visual acuity change, rather than an improvement in visual acuity,” Dr. Crnic-Rein said.

Outcomes showed 7% of patients lost 3 lines of visual acuity. The mean postop refractive error of all patients was –0.1 D (SD 3.2 D); anisotropia was 2.01 D.

“We were happy to see that the lens was well tolerated in follow-ups. There was not much change in visual acuity, and the complication rate was very low,” Dr. Crnic-Rein said.